In a first, the Food and Drug Administration has given approval to a drug that is produced on a 3-D printer. The pill, produced by Aprecia Pharmaceuticals, treats seizures. It’s expected to hit the market in the first quarter of 2016.

Another benefit of the process, says Aprecia, the drug’s maker, is that it allows a high drug load – up to 1,000 mg – to be delivered in a single dose. The 3-D printing process creates a pill that has “a porous formulation that rapidly disintegrates with a sip of liquid,” the company says.

Aprecia says it based its printing platform on technology that originated at the Massachusetts Institute of Technology.

The technology allows the formulation to quickly disintegrate with a sip of liquid. However the precise mechanism by which Levetiracetam exerts its antiepileptic effect is unknown. It will be available as 250mg, 500mg, 750mg, and 1000mg strengths in a spearmint flavor and is expected to be available for prescription in the first quarter of 2016.

About The Author

Ethelyn Brye is an award-winning author and blogger. Growing up in Switzerland and influenced by renowned Swiss design and a lot of fresh mountain air, she attended and completed design studies in Geneva. Post graduation she moved to Washington State to work for a design firm, but her love of writing brought her to Cyanosaur. She’s highly interested in strategy rpgs, mountain climbing, board games with friends and skiing. She lives in Seattle, Washington, with her lovely cat Armstrong.

Leave a Reply

Your email address will not be published.